94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Hongfeng Huang1,2,3†
Qixia Shen1,2,3†
Jingyi Zhou1,2,3
Xiuyan Yang1,2,3
Qiuqin Cai1,2,3Jia Shen1,2,3Shi Feng1,2,3Wenqing Xie1,2
Hong Jiang1,2,3*
Jianghua Chen1,2,3*- 1Kidney Disease Center, The First Affiliated Hospital, College of Medicine, Zhejiang University School of Medicine, Hangzhou, China
- 2Key Laboratory of Nephropathy, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
- 3Institute of Nephropathy, Zhejiang University, Hangzhou, China
A Corrigendum on
Immune tolerance induced by hematopoietic stem cell infusion after HLA identical sibling kidney transplantation
by Huang H, Shen Q, Zhou J, Yang X, Cai Q, Shen J, Feng S, Xie W, Jiang H and Chen J (2022) Front. Immunol. 13:995243. doi: 10.3389/fimmu.2022.995243
In the published article, there was an error in the Funding statement. Previously, it read: “This work was supported by grants from the Natural Science Foundation of Zhejiang Province, Zhejiang, China (Grant No. LY20H020003) and Medicine and Health Science and Technology Plan Projects of Zhejiang Province, Zhejiang China (Grant No. 2019KY377).” However, two more fundings supporting this research, the National Natural Science Foundation of China (NSFC 82070767, 81770750), should also be added to the Funding section. The correct Funding statement appears below.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Funding
This work was supported by grants from the Natural Science Foundation of Zhejiang Province, Zhejiang, China (Grant No. LY20H020003), Medicine and Health Science and Technology Plan Projects of Zhejiang Province, Zhejiang China (Grant No. 2019KY377) and the National Natural Science Foundation of China (NSFC 82070767, 81770750).
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: hematopoietic stem cell infusion, immune tolerance, immunosuppression withdrawal, chimerism, GVHD, kidney transplantation
Citation: Huang H, Shen Q, Zhou J, Yang X, Cai Q, Shen J, Feng S, Xie W, Jiang H and Chen J (2022) Corrigendum: Immune tolerance induced by hematopoietic stem cell infusion after HLA identical sibling kidney transplantation. Front. Immunol. 13:1052676. doi: 10.3389/fimmu.2022.1052676
Received: 24 September 2022; Accepted: 11 October 2022;
Published: 19 October 2022.
Edited and Reviewed by:
Zhenhua Dai, Guangdong Provincial Academy of Chinese Medical Sciences, ChinaCopyright © 2022 Huang, Shen, Zhou, Yang, Cai, Shen, Feng, Xie, Jiang and Chen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Jianghua Chen, Y2hlbmppYW5naHVhQHpqdS5lZHUuY24=; Hong Jiang, amlhbmdob25nOTYxMTA2QHpqdS5lZHUuY24=
†These authors have contributed equally to this work